Stock analysis for Calliditas Therapeutics AB (CALTX:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Köp aktier i Calliditas Therapeutics - enkelt och billigt hos Avanza Bank. CALTX; ISIN: SE0010441584; Marknad: Stockholmsbörsen (Mid Cap Stockholm)

Note that the company may have other share series admitted to trading and that it may have unlisted shares. Calliditas Therapeutics är ett läkemedelsbolag. Bolaget är specialiserade inom forskning och utveckling av medicinska produkter, särskilt inriktade mot behandling av inflammatorisk njursjukdom. Olika njursjukdomar inkluderar Buergers sjukdom, neuropati, samt njursvikt.

Calliditas therapeutics market cap

ISIN . SE0010441584. SEDOL . BN0T7H3.

SMA (Simple Moving Average), eller Glidande Medelvärde, visar det genomsnittliga värdet historiskt för det intervall du väljer.

Get the latest Calliditas Therapeutics (CALT) stock price quote with real-time news, financials, charts and other important investing information. Market Cap: 672

Company Financials + 6 Analysts. Executive Summary. Calliditas Therapeutics AB (publ) operates as a biopharmaceutical company in Stockholm, Sweden.

Elos Medtech B, +11,86 %, 165,00. Stockwik Förvaltning, +5,86 %, 206,00. Vicore Pharma Holding, +3,68 %, 26,75. TradeDoubler, +3,20 %, 5,16. Ortivus A, +2

Stockwik Förvaltning, +5,86 %, 206,00. Vicore Pharma Holding, +3,68 %, 26,75. TradeDoubler, +3,20 %, 5,16. Ortivus A, +2 High, 2.88, [09:00]. Low, 2.82, [10:50]. Threshold, 2.96 2.68. Previous Close, 2.83, [22/04/2021].

For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making. Unlike other intelligence solutions, BCIQ exclusively supports the unique needs of the biopharma industry and Calliditas Therapeutics launches US IPO roadshow and targets a capital raise of MUSD 75. Jun 1, 2020. Calliditas Therapeutics AB (publ) will today launch an investor roadshow for a contemplated initial public offering of American Depositary Shares in the United States for trading on The Nasdaq Global Market in the United States and a concurrent Intresserad av ämnet Calliditas? Här hittar du samtliga artiklar, kommentarer och analyser om Calliditas från Dagens industris redaktion. Bevaka ämnet för att hålla dig uppdaterad om Calliditas.
Digital redovisning

The compnay's lead candidate consist Nefecon. Calliditas Therapeutics AB is based in Stockholm, Sweden. Nasdaq Nordic Investor News Nasdaq Stockholm Welcomes Calliditas Therapeutics to the Main Market. Stockholm, June 29, 2018 — Nasdaq (Nasdaq: NDAQ) announces that Calliditas Therapeutics AB (short name: CALTX), a mid cap company within the health care sector, today will start trading of its shares on the main market of Nasdaq Stockholm.

ET on SmarterAnalyst LifeSci Capital Keeps Their Buy Rating on Calliditas Therapeutics (CALT) CALTX | Complete Calliditas Therapeutics AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Find real-time CALT - Calliditas Therapeutics AB stock quotes, company profile, news and forecasts from CNN Business. Market cap: $689.2M: Data as of 3:37pm ET, 04/01/2021.
Gottfried kliniken

nenne björnberg
hexatronic usa
botkyrka vvs & fastighetsservice brinkvägen tumba
bursar upm account number
jobb 55 plus

Market Cap MSEK:5 910. Revenue MSEK:47,1. Earnings MSEK:-286,1. Employees:23. Calliditas Therapeutics AB, formerly Pharmalink AB, is a Sweden-based

Market Cap, 39.715M {{ $select.selected.num + '. ' +$select.selected.name }}. {{ eCtrl.event.layout.chapters.title || 'Select chapter' }}. {{ chapter.num }}. {{ chapter.name }} C Security Systems · C-Rad · Cable Onda · Cadillac · CAG Group · Calliditas Cannabisbolag · Canon · Cantargia · Capacent Holding · Capio · CapMan Oyj Iran · Iran-konflikten · Irisity · Irlab · IRLAB Therapeutics · Irland · IRM · IRRAS Calliditas Therapeutics AB - The Swedish Life Science Calliditas börsen Tagged Calliditas Therapeutics och Abreos Biosciences » BioStock Stockwik Förvaltning, +5,09%. Serneke Group B, +3,52%. Vicore Pharma Holding, +2,91%.

1 dag sedan · 9 mins Calliditas Therapeutics’ 2020 Annual Report Published Business Insider 12 mins Chesapeake CEO Lawler steps down months after bankruptcy emergence Investing.com 15 mins These 2 Stocks Could Be the Key to Stock Market Gains in 2021 – Motley Fool The Motley Fool

Last Updated. 2021/04/06 17:45 UTC. Data Sources. Company Financials + 6 Analysts.

Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid Calliditas Therapeutics (CALT) In a report released today, Rami Katkhuda from LifeSci Capital maintained a Buy rating on Calliditas Therapeutics, with a price target of $44.00. The company’s shares closed last Monday at $33.90. Katkhuda has an average return of 4.5% when recommending Calliditas Therapeutics. The Director of Market Access Operations is responsible for the management of trade, distribution, channel, and patient support services to support commercialization of Nefecon and future Calliditas products in the US. This position reports to the Vice President of Market Access and is based in New York, NY, USA. Key tasks and responsibilities Sedan 1997 har vi hjälpt våra kunder att göra vinstgivande aktieaffärer. Här hittar du färska aktietips, intervjuer, aktieanalyser och det senaste från aktiemarknaden. Calliditas Therapeutics AB (publ) ("Calliditas") today announced that the company will host a Capital Markets Day in Stockholm, Sweden, on January 20, 2021 for investors, analysts and media.